Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP342048.RA2b9_mHBCcNHAkjTh35ds9ZSdWDZZRtxbDT58vL2XX4w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP342048.RA2b9_mHBCcNHAkjTh35ds9ZSdWDZZRtxbDT58vL2XX4w130_assertion type Assertion NP342048.RA2b9_mHBCcNHAkjTh35ds9ZSdWDZZRtxbDT58vL2XX4w130_head.
- NP342048.RA2b9_mHBCcNHAkjTh35ds9ZSdWDZZRtxbDT58vL2XX4w130_assertion description "[The present study investigated CYP2C9 in regard to its allelic variants in 23 tumor samples (10 breast tumors, 1 breast tumor cell line, 5 brain tumors, 7 glioma cell lines) with restriction fragment length polymorphism polymerase chain reaction (RFLP-PCR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP342048.RA2b9_mHBCcNHAkjTh35ds9ZSdWDZZRtxbDT58vL2XX4w130_provenance.
- NP342048.RA2b9_mHBCcNHAkjTh35ds9ZSdWDZZRtxbDT58vL2XX4w130_assertion evidence source_evidence_literature NP342048.RA2b9_mHBCcNHAkjTh35ds9ZSdWDZZRtxbDT58vL2XX4w130_provenance.
- NP342048.RA2b9_mHBCcNHAkjTh35ds9ZSdWDZZRtxbDT58vL2XX4w130_assertion SIO_000772 16475710 NP342048.RA2b9_mHBCcNHAkjTh35ds9ZSdWDZZRtxbDT58vL2XX4w130_provenance.
- NP342048.RA2b9_mHBCcNHAkjTh35ds9ZSdWDZZRtxbDT58vL2XX4w130_assertion wasDerivedFrom befree-20150227 NP342048.RA2b9_mHBCcNHAkjTh35ds9ZSdWDZZRtxbDT58vL2XX4w130_provenance.
- NP342048.RA2b9_mHBCcNHAkjTh35ds9ZSdWDZZRtxbDT58vL2XX4w130_assertion wasGeneratedBy ECO_0000203 NP342048.RA2b9_mHBCcNHAkjTh35ds9ZSdWDZZRtxbDT58vL2XX4w130_provenance.